The 2025 results demonstrate Paysign’s expanding presence across the healthcare ecosystem. Substantial growth in patient and client savings highlights the advanced efficacy of the company’s solutions ...
As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...
TORONTO, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potential to Address a Significant Unmet Need in Lung Transplant Medicine and ...
(MENAFN- GlobeNewsWire - Nasdaq) Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect to have investigational ...
In the summer of 2024, the University of Iowa’s College of Pharmacy appointed Marlow Hicks as its new pharmaceuticals director. Since 1885, the UI’s College of Pharmacy has maintained several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback